Head-to-head · Cost-Efficiency Index
Somira Health vs Tablet Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Somira Health
Shoppers who want clear, honest side-by-side monthly-vs-quarterly pricing without a hidden prepay trap.
Visit Somira HealthTablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthThe verdict
Somira Health and Tablet Health tie on the Cost-Efficiency Index at 57/100, so neither wins outright on the numbers. For most shoppers we'd start with Somira Health (ranked #312, a hair above #315) — Shoppers who want clear, honest side-by-side monthly-vs-quarterly pricing without a hidden prepay trap. But Tablet Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Somira Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Somira Health | Tablet Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 57/100 |
| Semaglutide / mo | $189/mo (compounded) | $199/mo (compounded) |
| Tirzepatide / mo | $239/mo (compounded) | $299/mo (compounded) |
| Semaglutide / yr (modeled) | $2,268 | $2,388 |
| Tirzepatide / yr (modeled) | $2,868 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #312 | #315 |
Somira Health
57/100Where the value is
- Both monthly and quarterly prices disclosed together -- no disguised 'starting at' prepay trick
- Four named, checkable compounding pharmacy partners across four states
- Serves all 50 states
The tradeoffs
- No medical director named on reachable pages
- True monthly (non-prepay) price is noticeably higher than the quoted quarterly rate
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.